advertisement
Kass MA 12
Showing records 1 to 12 | Display all abstracts from Kass MA116890 Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc
Leshno A
Eye 2024; 38: 1549-1555
117071 Polygenic Risk Scores for Glaucoma Onset in the Ocular Hypertension Treatment Study
Singh RK
JAMA ophthalmology 2024; 142: 356-363
116890 Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc
Bommakanti N
Eye 2024; 38: 1549-1555
117071 Polygenic Risk Scores for Glaucoma Onset in the Ocular Hypertension Treatment Study
Zhao Y
JAMA ophthalmology 2024; 142: 356-363
116890 Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc
De Moraes CG
Eye 2024; 38: 1549-1555
117071 Polygenic Risk Scores for Glaucoma Onset in the Ocular Hypertension Treatment Study
Elze T; Fingert J
JAMA ophthalmology 2024; 142: 356-363
116890 Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc
Gordon MO
Eye 2024; 38: 1549-1555
117071 Polygenic Risk Scores for Glaucoma Onset in the Ocular Hypertension Treatment Study
Gordon M
JAMA ophthalmology 2024; 142: 356-363
116890 Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc
Kass MA; Cioffi GA
Eye 2024; 38: 1549-1555
117071 Polygenic Risk Scores for Glaucoma Onset in the Ocular Hypertension Treatment Study
Kass MA; Luo Y
JAMA ophthalmology 2024; 142: 356-363
116890 Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc
Liebmann JM
Eye 2024; 38: 1549-1555
117071 Polygenic Risk Scores for Glaucoma Onset in the Ocular Hypertension Treatment Study
Pasquale LR; Scheetz T; Segrè AV; Segrè AV; Wiggs JL; Zebardast N
JAMA ophthalmology 2024; 142: 356-363
